Table 3 Participant characteristics at screening for detecting ischemia-induced changes by 31P-MRS DEMz

From: Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T

Variable

Healthy lean young participants (n = 8)

Gender (m/f), n

6/2

Age (y)

28 ± 2

Body weight (kg)

71.5 ± 3.2

Body mass index (kg/m2)

22.9 ± 0.5

Fat mass (kg)

19.2 ± 2.7

Fat-free mass (kg)

52.3 ± 3.6

Fat percentage (%)

27.0 ± 3.5

Systolic blood pressure (mmHg)

116 ± 4 ( < 120)

Diastolic blood pressure (mmHg)

71 ± 2 ( < 80)

Creatinine (µmol/L)

79.8 ± 2.9 (60–115)

ASAT (U/L)

21.8 ± 1.4 (< 35)

ALAT (U/L)

15.9 ± 1.3 (< 45)

PT (s)

11.35 ± 0.12 (11–13.5)

aPTT(s)

29.5 ± 0.5 (30–40)

INR

1.08 ± 0.01 (0.8–1.1)

  1. Data are presented as mean ± SEM. ASAT aspartate aminotransferase, ALAT alanine aminotransferase, PT prothrombin time, aPTT partial thromboplastin time, INR international normalized ratio. Normal values in parentheses.